SALIX PHARMACEUTICALS Ltd

(NASDAQ: SLXP)
  • Trade now
  • Add to Watchlist
  • Get Chart
  • Print report
158.00 Down -0.97 -0.61%
DETAILS
Symbol Value ($)
Previous Close 158.97
Open 158.95
Day's High 160.88
Day's Low 157.42
Volume 418,555
Avg Daily Vol (13 Wks) 1.30 Mil
Bid 157.73
Bid Size 1
Ask 158.00
Ask Size 2
52-Wk High 162.38
52-Wk Low 65.14
Dividend Rate NA
Yield NA
  • Last trade 9/2/2014 3:14 PM ET
STOCKSCOUTER
FINANCIAL HIGHLIGHTS
Symbol Value ($)
Sales* 1.26 Bil
Income* 59.00 Mil
Sales Growth* +27.00%
Income Growth* +122.60%
Net Profit Margin 4.67%
Debt/Equity Ratio 3.85
Beta 1.27
EPS 0.90
Forward P/E 25.07
P/E 174.37
Market Cap 10.04 Bil
Shares Outstanding 63.69 Mil
  • More
  • * last 12 months
TOP FUNDS HOLDING
NAME % OWN
Vanguard Health Care Fund 2.87%
CREF Stock 1.99%
Vanguard Small Cap Index 1.64%
INTRADAY CHART Full-page chart
NEWS
PRESS REL
COMMENTARY
VIDEO ON MSN MONEY
DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

Financial data in US dollars | Page generated 3:15 PM ET
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money. Learn more
SYMBOL
LAST
CHANGE
SHARES
Quotes delayed at least 15 min
Sponsored by:
SLXP BUZZ
MARKET UPDATE
[BRIEFING.COM] The S&P 500 ran into a wall of resistance shortly after the top of the hour and dipped back to its lows of the morning (which weren't all that low). The pullback was emblematic of today's session where there simply hasn't been much con ... More
Sponsored by: